当前位置：首页 > 文献互助 > 互助详情

期刊论文A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies复制

用户7nEFK6amBq5Y 4个月前 205 已关闭

文献链接:复制

其他信息:

互助时间线

楼主用户7nEFK6amBq5Y关闭了求助

Development of Dual FLT3 and CHK1 PROTACs for the Treatment of AML 20分钟前

What Is the Rate-Limiting Step of Oxygen Reduction Reaction on Fe–N–C Catalysts? 2小时前

MDM2 Degrader as a Promising Therapeutic Strategy for Cancer Treatment 2小时前

Synthetic methods for high-entropy nanomaterials 5小时前

Understanding the role of short- and long-range intermolecular interactions in novel computational drug discovery 5小时前

Synthesis of Novel SRPK1-Targeting Hybrid Compounds Incorporating Antimetabolites for Cancer Therapy 5小时前

Discovery of a First-in-Class SLIT2 Binder Disrupting the SLIT2/ROBO1 Axis via DNA-Encoded Library (DEL) Screening 5小时前

Topoisomerase II inhibitors in oncology: an updated patent review (2016-present) 5小时前

Toll-like receptor agonists as cancer therapeutics: a patent review (2014–2024) 5小时前

A patent review of MLKL modulators (2023 – present) 5小时前

The effect of high tibial osteotomy on osteoarthritis of the knee. An arthroscopic study of 54 knee joints 7小时前

Effects of a contusion load on spinal cord with different curvatures 7小时前